Agios Pharmaceuticals, Inc.
Cambridge
Massachusetts
United States
349 articles about Agios Pharmaceuticals, Inc.
-
Shanghai ChemPartner Co., Ltd. and Agios Pharmaceuticals Expand Integrated Drug Discovery Research Collaboration
7/9/2009
-
Agios Pharmaceuticals' Focus of Drug Research – Cancer Metabolism – Selected for Stand Up To Cancer Grant
5/28/2009
-
Agios Pharmaceuticals Appoints David Schenkein, M.D. as CEO
5/27/2009
-
Agios Pharmaceuticals' Founders Author Science Review on Cancer Metabolism
5/21/2009
-
Agios Pharmaceuticals Highlights Extensive Cancer Metabolism Research at American Association for Cancer Research
4/30/2009
-
Agios Pharmaceuticals Appoints Charles Sawyers, M.D., to Scientific Advisory Board
2/6/2009
-
Agios Pharmaceuticals Expands Into 21,000 SqFt Facility
11/24/2008
-
Agios Pharmaceuticals Attracts Leading Cancer Metabolism Experts to Advisory Team
11/24/2008
-
Agios Pharmaceuticals Closes $33 Million Series A Funding
7/7/2008